Securities Code: 301408 Securities Abbreviation: HuaRen Health Announcement No.: 2026-025
Anhui HuaRen Health Pharmaceutical Co., Ltd. Announcement on Provision of Asset Impairment Provisions for 2025
The Company and all members of the Board of Directors guarantee the content of this information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
I. Overview of the Provision of Asset Impairment Losses This Time (I) Reasons for Provisioning Asset Impairment Losses To objectively, truthfully and accurately reflect the Company's assets and financial status, based on the principle of prudence, and in accordance with the relevant provisions of the "Accounting Standards for Business Enterprises" and accounting policies, Anhui HuaRen Health Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") conducted impairment tests on accounts receivable, other receivables, and inventory within the scope of the consolidated financial statements as of December 31, 2025, and made corresponding impairment provisions based on the test results. In accordance with the "Shenzhen Stock Exchange GEM Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 2 - Standardized Operation of GEM Listed Companies," and the "Articles of Association," the Company's provision of asset impairment losses this time does not require submission to the Board of Directors and Shareholders' Meeting for deliberation.
(II) Scope and Amount of Asset Impairment Provisions This Time The specific situation of the Company's provision of asset impairment losses for 2025 is as follows:
| Impairment Item | Amount of Impairment Provision This Period (Unit: RMB million) |
|---|---|
| Credit impairment loss | -1,473.91 |
| Accounts receivable impairment loss | -1,473.41 |
| Other receivables impairment loss | -0.50 |
| Asset impairment loss | -7,973.72 |
| Inventory price decline loss | -762.51 |
| Goodwill impairment loss | -7,211.20 |
| Total | -9,447.63 |
Notes: 1. The losses in the above table are shown as negative numbers. 2. Any discrepancy between the total number and the sum of individual items in the above table is due to rounding.
II. Specific Explanation of the Provision of Asset Impairment Losses Based on the "Accounting Standards for Business Enterprises" and the Company's accounting policies and other relevant regulations, as part of the Company's credit risk asset management, the Company uses aging to assess the impairment losses of accounts receivable and other receivables.
(I) Accounts Receivable The Company's methods for determining the expected credit loss of accounts receivable and accounting treatment are detailed in the "2025 Annual Report" of the Company, Section VIII Financial Report, "V. Significant Accounting Policies and Accounting Estimates—11. Financial Instruments," subsection "(6) Financial Instrument Impairment," and "V. Significant Accounting Policies and Accounting Estimates—13. Accounts Receivable."